×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SESSION 4: FACILITATION OUTSIDE THE REGULATORY WORLD
Session Chair(s)
Representative Invited
University Freiburg Inst. F.Pharmaceutical Sciences, Germany
Facilitation Outside the Regulatory World
Speaker(s)
CRO’s Perspective on Feasibility and Challenges with Paediatric Clinical Trials
Martine Dehlinger-Kremer, PhD
ICON Plc, Germany
Vice President Scientific Affairs, Pediatric Subject Matter Expert
HCP Voice on Practical Challenges/Suggestions
Mark Turner, MD, PhD, MRCP, FFPM
University of Liverpool, United Kingdom
Chief Executive Officer of the c4c- Stichting (c4c-S) & Professor of Neonatology
The Case for a Global Pediatric Clinical Trials Network; and Progress Towards that Goal
William R. Treem
Janssen Pharmaceutical Research and Development, United States
Senior Director, Pediatric Drug Development
Have an account?